The Genetically Engineered Vector Vaccine Market is experiencing strong momentum as advanced vaccine platforms redefine infectious disease prevention, viral vector innovation accelerates, and global investment in next-generation vaccines continues to expand. The global market was valued at approximately USD 3.5–3.99 billion in 2024–2025 and is projected to reach between USD 12.5...
